Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome‑mediated inflammation
Hui Feng, Xiaoyun Zhu, Yang Tang, et al.
International Journal of Molecular Medicine (2021) Vol. 48, Iss. 2
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention
Xiaoju Ma, Jingru Ma, Tian Leng, et al.
Renal Failure (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 73
A natural products solution to diabetic nephropathy therapy
Qichao Hu, Lan Jiang, Qi Yan, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108314-108314
Closed Access | Times Cited: 72
Astragali Radix: comprehensive review of its botany, phytochemistry, pharmacology and clinical application
Y. Liu, Xiaomei Song, Linwei Dan, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 3, pp. 165-218
Closed Access | Times Cited: 26
A Review of Medicinal Plants with Renoprotective Activity in Diabetic Nephropathy Animal Models
I Made Wisnu Adhi Putra, Nanang Fakhrudin, Arief Nurrochmad, et al.
Life (2023) Vol. 13, Iss. 2, pp. 560-560
Open Access | Times Cited: 30
Astragaloside IV ameliorate acute alcohol-induced liver injury in mice via modulating gut microbiota and regulating NLRP3/caspase-1 signaling pathway
Shangong Wu, Fei Wen, Xiangbin Zhong, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 29
Pharmacological potential of Astragali Radix for the treatment of kidney diseases
Yue Shi, Xiujie Shi, Mingming Zhao, et al.
Phytomedicine (2023) Vol. 123, pp. 155196-155196
Closed Access | Times Cited: 27
Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
Daniela Maria Tănase, Emilia Valasciuc, Evelina Maria Gosav, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8162-8162
Open Access | Times Cited: 26
The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease
Yiwei Gao, Xin Su, Taiqi Xue, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114598-114598
Open Access | Times Cited: 22
Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease
Yonghui Hu, Wangna Tang, Wenjie Liu, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1605-1620
Open Access | Times Cited: 25
The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy
Bethany M. Williams, Chelsy L. Cliff, K. Lee, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 23
Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease
Yan Wang, Zhun Sui, Mi Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease
Dan‐Qian Chen, Jun Wu, Ping Li
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy
Linlin Sun, Miao Ding, Fuhua Chen, et al.
PeerJ (2023) Vol. 11, pp. e14826-e14826
Open Access | Times Cited: 12
Astragaloside IV inhibits cell viability and glycolysis of hepatocellular carcinoma by regulating KAT2A-mediated succinylation of PGAM1
Yuanzhang Zhu, Fei Lu
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Research Progress on the Regulatory Effects and Mechanisms of Traditional Chinese Medicine on Renal Inflammatory Signal Transduction Pathways in Diabetic Nephropathy
文 罗
Traditional Chinese Medicine (2025) Vol. 14, Iss. 04, pp. 1566-1571
Closed Access
Astragaloside IV Regulates Insulin Resistance and Inflammatory Response of Adipocytes via Modulating MIR-21/PTEN/PI3K/AKT Signaling
Xuxi Guo, Taoqing Yin, Dongni Chen, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 23, Iss. 12, pp. 1538-1547
Closed Access | Times Cited: 9
Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications
Lvzhuo Zhang, Shifeng He, Lian Liu, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 7, pp. 3564-3582
Closed Access | Times Cited: 3
Radix Astragali and Its Representative Extracts for Diabetic Nephropathy: Efficacy and Molecular Mechanism
Hui‐zhong Xue, Yu Chen, Shi-Dong Wang, et al.
Journal of Diabetes Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 3
Exploring the role of NLRP3 inflammasome in diabetic nephropathy and the advancements in herbal therapeutics
Jiangyuan Jin, Mianzhi Zhang
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Astragaloside IV protects renal tubular epithelial cells against oxidative stress‐induced injury by upregulating CPT1A‐mediated HSD17B10 lysine succinylation in diabetic kidney disease
Meng Wang, Qiurui Li, Shang Wang, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 9, pp. 4519-4540
Closed Access | Times Cited: 2
Saponins as potential novel NLRP3 inflammasome inhibitors for inflammatory disorders
Jiamei Tang, Yaxiao Liu, Ying Wu, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 10-11, pp. 757-792
Closed Access | Times Cited: 2
Chinese herbal medicine and active ingredients for diabetic cardiomyopathy: molecular mechanisms regulating endoplasmic reticulum stress
Lianjun Ao, Zhengtao Chen, Jiacheng Yin, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
The efficacy and potential mechanism of Danggui Buxue Decoction in treating diabetic nephropathy: A meta-analysis and network pharmacology
Yan Zhang, Lijuan Jiang, Jiaojiao Xue, et al.
Medicine (2023) Vol. 102, Iss. 14, pp. e33481-e33481
Open Access | Times Cited: 5
Efficacy of Danggui Buxue decoction on diabetic nephropathy-induced renal fibrosis in rats and possible mechanism.
Ye Zhao, Xian Wang, G U Ling, et al.
PubMed (2023) Vol. 43, Iss. 3, pp. 507-513
Closed Access | Times Cited: 5
Hedysarum polybotrys polysaccharide attenuates renal inflammatory infiltration and fibrosis in diabetic mice by inhibiting the HMGB1/RAGE/TLR4 pathway
Changqing Xu, Yanxu Cheng, Z. Liu, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 4
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top